VTR and Merck are noted as high-yield healthcare stocks.
1 report, 1 independent
Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
VTR and Merck are noted as high-yield healthcare stocks.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Amgen and Merck are currently competing against each other in the market for investor capital.
- Healthcare stocks surged to record highs on August 19, 2026, amid market excitement over drug breakthroughs involving Moderna, Amgen, and Merck.
- Welltower, VTR, Omega Healthcare, Universal Health Realty, and LTC Properties are discussed in the context of high dividend yields in the healthcare sector, including dividend cuts during the COVID-19 pandemic.
- Merck's stock price increased following positive drug performance involving Summit Therapeutics.
Coverage
Newest first; wire copies grouped- Motley Fool3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August Merck is an industry giant that has proved time and again it can innovate for the future. Ventas has positioned itself to grow its busin